Table 3.
Factors associated with receiving follow-up care for late effects in survivors reporting at least one late effect. Univariable and multivariable logistic regression models are presented (n = 1162)
| Factors associated with receiving follow-up carea | |||||
|---|---|---|---|---|---|
| Univariable | Multivariable | ||||
| Mean | OR (95% CI) | p value | p value | ||
| Age at diagnosis | 26.3 | 0.99 (0.98–1.00) | 0.113 | ||
| Age at survey | 42.8 | 0.99 (0.98–0.99) | 0.016 | 0.98 (0.97–0.99) | 0.001 |
| Time since first diagnosis | 15.9 | 0.99 (0.97–1.01) | 0.204 | ||
| n | OR (95% CI) | p value | OR (95% CI) | p value | |
| Sex | 0.380 | 0.688 | |||
| Female | 828 | 1 | |||
| Male | 334 | 0.89 (0.67–1.16) | 0.94 (0.71–1.26) | ||
| Educationb | 0.011 | 0.012 | |||
| ≤ High school | 503 | 1 | 1 | ||
| > Higher education | 659 | 1.38 (1.08–1.84) | 1.39 (1.08–1.80) | ||
| Diagnosis | 0.028 | ||||
| Childhood cancer | 368 | 1 | |||
| Melanoma | 43 | 0.44 (0.21–0.95) | |||
| Breast cancer | 398 | 0.77 (0.57–1.04) | |||
| Colorectal cancer | 75 | 0.42 (0.23–0.77) | |||
| Non-Hodgkin’s lymphoma | 175 | 0.84 (0.58–1.23) | |||
| Leukemias | 99 | 0.98 (0.62–1.55) | |||
| Treatmentc | 0.006 | 0.124 | |||
| Minimal | 38 | 1 | 1 | ||
| Local | 81 | 1.76 (0.68–4.55) | 1.48 (0.57–3.89) | ||
| Systemic | 174 | 1.45 (0.60–3.54) | 0.91 (0.36–2.29) | ||
| Multimodal | 869 | 2.47 (1.07–5.47) | 1.43 (0.61–3.38) | ||
| Relapse | 0.071 | ||||
| Yes | 171 | 1.36 (0.97–1.90) | |||
| No | 987 | 1 | |||
| Number of late effects | < 0.001 | < 0.001 | |||
| 1–2 | 437 | 1 | 1 | ||
| 3–4 | 339 | 1.35 (0.98–1.85) | 1.33 (0.96–1.85) | ||
| > = 5 | 386 | 2.53 (1.88–3.40) | 2.54 (1.85–3.48) | ||
CI confidence interval, OR odd ratio
aOutcome is codes as 0 = not receiving follow-up care and 1 = having received/receiving follow-up care. Because of multicollinearity between diagnosis and treatment, only treatment was included in the final model. b “< High school” includes all schooling up to and including high school (13 years of schooling); “> High school” includes any higher education at university of university college level. cMissing treatment information on 3 patients. Minimal (melanoma survivors with minimal surgery only), local (local surgery and/or radiotherapy), systemic (single chemotherapy or other systemic treatments), or multimodal (systemic treatment with surgery, radiotherapy or stem cell transplantation) treatment